Neisseria gonorrhoeae antmicrobial resistance: detection and propagation

淋病奈瑟菌抗菌素耐药性：检测和传播

• 批准号: nhmrc : 1025517
• 负责人: A/Pr David Regan
• 金额: $ 29.01万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/neisseria-gonorrhoeae-antmicrobial-detection-propagation/110432
• 关键词: Neisseria; gonorrhoeae; antmicrobial; resistance; detection

Neisseria gonorrhoeae, the pathogen that causes gonorrhoea, has developed resistance to multiple classes of antibiotics. The last remaining class of antibiotics that can successfully be used for general treatment of gonorrhoea is extended spectrum cephalosporins (ESCs). However, we are now starting to see Neisseria gonorrhoeae isolates with early signs of ESC resistance. This research will use molecular technology and mathematical modelling to investigate Neisseria gonorrhoeae antimicrobial resistance in Australia.

淋病奈瑟菌是引起淋病的病原体，它已经对多种抗生素产生了耐药性。最后一类可以成功用于淋病一般治疗的抗生素是超广谱头孢菌素 (ESC)。然而，我们现在开始看到淋病奈瑟菌分离株具有 ESC 耐药性的早期迹象。这项研究将利用分子技术和数学模型来调查澳大利亚淋病奈瑟菌的抗菌耐药性。